Xfeed
feeding hot melt to all melters in your production.
The new dimension in process optimisation!
You will find useful information for your daily work here.
Baumer hhs provides relevant information for many industries and regions worldwide.
EU Directive 2011/62/EU for pharmaceutical packaging
By adopting Directive 2011/62/EU on 8 June 2011, the EU paved the way to making it easier to identify falsified medicinal products in human medicine for the protection of patients' health.
The tamper evidence rules make it harder to manipulate packaging. The packaging is sealed in such a way that premature opening or manipulation of the packaging is detected by supply chain partners, such as the dispensing pharmacist. One object of this regulation is to prevent the re-packing of falsified medicinal products in genuine packaging.
The setting and maintaining of high quality standards plays a central role, especially for packaging systems with high throughputs. This is particularly true when it is a question of protecting and maintaining health, namely in the medical sector and the food industry. However, mix-ups also at least have an effect on production efficiency in less sensitive packing sectors and lead to annoying complaints. For this reason, Baumer hhs does not make do with simple sensors for monitoring its systems, but has always opted for intelligent mechanisms that only release a product once all quality criteria have been met, without exception. With over 30 years of experience, Baumer hhs is the leader in the field of quality control in the production of folding cartons and print finishing.